Literature DB >> 9699776

Types of asthma and wheezing.

F D Martinez1, P J Helms.   

Abstract

There is now convincing evidence that childhood asthma is a spectrum of different conditions that are manifested by recurrent symptoms of bronchial obstruction. Risk factors such as age, genetic background, degree of maturation at birth and allergic sensitization, amongst others, are important in determining asthma-like manifestations at different times during childhood. Although efforts have been made to differentiate "wheezing syndromes" occurring during childhood, these efforts have been made more difficult by the significant degree of overlap between them. Nevertheless, the evidence suggests that recurrent obstructive symptoms remit in a large number of children who develop these symptoms during the first 3 yrs of life, and low lung function seems to be the main risk factor for these transient episodes. On the other hand, children who will go on to develop persistent wheezing beyond infancy and early childhood usually have a family history of asthma and allergies and present with allergic symptoms very early in life. Recent studies suggest that the latter also show acute immune responses to viruses that are different from those of transient wheezers. Identification of specific inflammatory markers for persistent wheezing at the time of the first lower respiratory symptoms may be a necessary step for the establishment of successful strategies for the prevention of asthma in the future.

Entities:  

Mesh:

Year:  1998        PMID: 9699776

Source DB:  PubMed          Journal:  Eur Respir J Suppl        ISSN: 0904-1850


  11 in total

1.  A parent-completed respiratory questionnaire for 1-year-old children: repeatability.

Authors:  Marie-Pierre F Strippoli; Michael Silverman; Gisela Michel; Claudia E Kuehni
Journal:  Arch Dis Child       Date:  2007-05-14       Impact factor: 3.791

Review 2.  Asthma in children: are chlamydia or mycoplasma involved?

Authors:  S Esposito; N Principi
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

3.  Acquisition, remission, and persistence of eczema, asthma, and rhinitis in children.

Authors:  H Zhang; A Kaushal; N Soto-Ramírez; A H Ziyab; S Ewart; J W Holloway; W Karmaus; H Arshad
Journal:  Clin Exp Allergy       Date:  2018-02-27       Impact factor: 5.018

4.  Family history and the risk of early-onset persistent, early-onset transient, and late-onset asthma.

Authors:  S J London; W James Gauderman; E Avol; E B Rappaport; J M Peters
Journal:  Epidemiology       Date:  2001-09       Impact factor: 4.822

5.  Atopy and house dust mite sensitization as risk factors for asthma in children.

Authors:  Jung-Wook Shin; Ju-Hee Sue; Tae-Won Song; Kyung-Won Kim; Eun-Soo Kim; Myung Hyun Sohn; Kyu-Earn Kim
Journal:  Yonsei Med J       Date:  2005-10-31       Impact factor: 2.759

Review 6.  Management of asthma in young children.

Authors:  Marianna Sockrider
Journal:  Curr Allergy Asthma Rep       Date:  2002-11       Impact factor: 4.806

7.  Maternal immune markers in serum during gestation and in breast milk and the risk of asthma-like symptoms at ages 6 and 12 months: a longitudinal study.

Authors:  Nelís Soto-Ramírez; Wilfried Karmaus; Mitra Yousefi; Hongmei Zhang; Jihong Liu; Venugopal Gangur
Journal:  Allergy Asthma Clin Immunol       Date:  2012-07-17       Impact factor: 3.406

8.  Determinants in early life for asthma development.

Authors:  Hugo P S Van Bever
Journal:  Allergy Asthma Clin Immunol       Date:  2009-11-09       Impact factor: 3.406

9.  A measure for quantifying the impact of housing quality on respiratory health: a cross-sectional study.

Authors:  Michael D Keall; Julian Crane; Michael G Baker; Kristin Wickens; Philippa Howden-Chapman; Malcolm Cunningham
Journal:  Environ Health       Date:  2012-05-14       Impact factor: 5.984

10.  Prescription of respiratory medication without an asthma diagnosis in children: a population based study.

Authors:  Mira G P Zuidgeest; Liset van Dijk; Henriette A Smit; Johannes C van der Wouden; Bert Brunekreef; Hubert G M Leufkens; Madelon Bracke
Journal:  BMC Health Serv Res       Date:  2008-01-22       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.